The 10 Steps to Launching an OTC Drug the Right Way

Launching an OTC drug involves more than just mixing ingredients and designing a label. It requires strict adherence to FDA regulations and Good Manufacturing Practices (GMP). In our recent webinar, Bill Neumann, VP of QA and Regulatory Affairs, outlined a logical, 10-step process to ensure a compliant and efficient launch.

Continue Reading >

RIPT Testing Essentials: How to Validate Hypoallergenic Claims for Cosmetic Products

In today’s cosmetic and personal care product market, claims such as “hypoallergenic,” “suitable for sensitive skin,” or “non-irritating” are powerful differentiators. Consumers want products that are gentle, safe, and less likely to cause adverse skin reactions. However, from a regulatory, scientific, and brand credibility perspective, such claims require solid evidence.

Continue Reading >

3 Testing Traps That Can Derail Your OTC Product Launch

Launching a new product is a high-stakes endeavor. You depend on testing data to validate performance, support claims, and satisfy regulators. Yet many companies stumble before they even get to market. Below are three common “testing traps” that can silently undermine your launch readiness and what you should do to

Continue Reading >

Photoallergy vs Phototoxicity Testing: Regulatory Guidelines & Best Practices in Photobiology Safety Assessment

In R&D, formulation, and for compliance teams working in cosmetics, personal care, or topical pharmaceutical products, understanding the differences between photoallergy and phototoxicity is essential to ensure product safety, meet regulatory requirements, and prevent adverse skin reactions. In this blog, we’ll review the relevant regulatory frameworks and discuss how we

Continue Reading >

Blog Categories

For Businesses

For Panelists

Recent Posts